Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population-Reply

Peter S Hall^{1

2}, David A Cairns¹, Matthew T Seymour^{1

3}

Affiliations

Free article

Comment

Peter S Hall et al. JAMA Oncol. 2021.

Free article

. 2021 Nov 1;7(11):1725.

doi: 10.1001/jamaoncol.2021.4010.

Peter S Hall^{1

2}, David A Cairns¹, Matthew T Seymour^{1

3}

No abstract available

Comment on

Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial.
Hall PS, Swinson D, Cairns DA, Waters JS, Petty R, Allmark C, Ruddock S, Falk S, Wadsley J, Roy R, Tillett T, Nicoll J, Cummins S, Mano J, Grumett S, Stokes Z, Kamposioras KV, Chatterjee A, Garcia A, Waddell T, Guptal K, Maisey N, Khan M, Dent J, Lord S, Crossley A, Katona E, Marshall H, Grabsch HI, Velikova G, Ow PL, Handforth C, Howard H, Seymour MT; GO2 Trial Investigators. Hall PS, et al. JAMA Oncol. 2021 Jun 1;7(6):869-877. doi: 10.1001/jamaoncol.2021.0848. JAMA Oncol. 2021. PMID: 33983395 Free PMC article. Clinical Trial.
Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population.
Mizutani T. Mizutani T. JAMA Oncol. 2021 Nov 1;7(11):1724-1725. doi: 10.1001/jamaoncol.2021.4007. JAMA Oncol. 2021. PMID: 34473208 No abstract available.
Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population.
Wang X, Kim DH, Wei LJ. Wang X, et al. JAMA Oncol. 2021 Nov 1;7(11):1723-1724. doi: 10.1001/jamaoncol.2021.4004. JAMA Oncol. 2021. PMID: 34473211 No abstract available.